UroGen Pharma

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. It has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs.

CEO

Elizabeth Barrett

CEOElizabeth Barrett

Employees

195

Employees195

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2004

Founded2004

Employees

195

Employees195

URGN Key Statistics

Market cap

202.38M

Market cap202.38M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

59.27K

Average volume59.27K

High today

$8.90

High today$8.90

Low today

$8.33

Low today$8.33

Open price

$8.36

Open price$8.36

Volume

75.00K

Volume75.00K

52 Week high

$12.63

52 Week high$12.63

52 Week low

$4.85

52 Week low$4.85

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

URGN Earnings

-$1.35

-$0.90

-$0.45

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 21, Pre-Market

ActualExpected Mar 21, Pre-Market